SCHEMBL3260451

SCHEMBL3260451

COc1ccc(N2CCN(C(=O)C(=O)Nc3cc(NCCNC(C)=O)nc(-c4ccccc4)n3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A2 P43004 1/20 0.52
▸ TP53 P04637 1/20 0.46
▸ TSHR P16473 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ CLK4 Q9HAZ1 1/20 0.44
▸ MTNR1A P48039 1/20 0.44
▸ MTNR1B P49286 1/20 0.44
▸ ADORA3 P0DMS8 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ USP2 O75604 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ SIRT1 Q96EB6 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ NTSR1 P30989 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ DRD2 P14416 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156095 0.94 SLC1A2 (0.46) SLC1A2TP53TSHRCYP1A2CYP3A4
SCHEMBL3166495 0.92 SLC1A2 (0.44) SLC1A2TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL3171368 0.92 ADORA3 (0.45) SLC1A2TSHRADORA3KMT2AUSP2
SCHEMBL3162484 0.91 MAPT (0.44) SLC1A2ADORA3KMT2APOLBMAPK1
SCHEMBL3155601 0.91 ADORA2A (0.42) SLC1A2TSHRCYP1A2CYP3A4CYP2C19
SCHEMBL3163864 0.90 LMNA (0.43) TP53ADORA3KMT2AUSP2POLB
SCHEMBL3164671 0.89 ADORA2A (0.41) SLC1A2TSHRCYP1A2CYP3A4CLK4
SCHEMBL3177170 0.89 NTSR1 (0.46) SLC1A2TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL3161165 0.88 ABCG2 (0.45) CYP1A2CYP3A4CYP2D6CLK4ADORA3
SCHEMBL3171564 0.87 CHRM4 (0.45) SLC1A2TP53TSHRCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback